Armand James Quick (1894–1978): The Architect of Modern Hemostasis
Armand James Quick was a polymathic scientist—a chemist, physician, and educator—whose work fundamentally transformed our understanding of how human blood clots. While his name might not be a household word, every patient who has ever taken a blood thinner or undergone a pre-operative screening owes a debt to his ingenuity. He is best known for developing the "Quick Test" (Prothrombin Time), a diagnostic cornerstone that bridged the gap between theoretical biochemistry and bedside medicine.
1. Biography: From the Laboratory to the Clinic
Armand James Quick was born on July 18, 1894, in Theresa, Wisconsin. His academic journey was characterized by a relentless pursuit of cross-disciplinary knowledge. He earned his B.S. (1918) and M.S. (1919) from the University of Wisconsin-Madison, followed by a Ph.S. in Chemistry from the University of Illinois in 1922.
Despite his success as a chemist, Quick felt a calling toward the clinical application of his research. This led him to Cornell University Medical College, where he earned his M.D. in 1928. This rare combination of a PhD in chemistry and an MD allowed him to view medical problems through the lens of molecular reactions.
After a brief stint as an intern at Philadelphia General Hospital and a research fellowship at the University of Pennsylvania, Quick returned to his home state in 1935 to join the faculty of the Marquette University School of Medicine (now the Medical College of Wisconsin). He served as the Chairman of the Department of Biochemistry from 1944 to 1964 and remained active in research as a professor emeritus until his death on January 26, 1978.
2. Major Contributions: Decoding the Clot
Quick’s primary contribution to science was the development of the Prothrombin Time (PT) test in 1935. At the time, the mechanism of blood coagulation was a "black box." Doctors knew some people bled too much (hemophilia) and others clotted too easily, but they had no way to measure the blood's clotting potential.
- The Prothrombin Time (PT) Test: Quick discovered that by adding a fixed amount of thromboplastin (tissue factor) and calcium to plasma, he could measure the exact number of seconds it took for a fibrin clot to form. This "one-stage" method allowed clinicians to quantify the activity of prothrombin, a key protein in the clotting cascade.
- Vitamin K and Jaundice: Quick used his test to prove that the bleeding tendencies in patients with obstructive jaundice were caused by a deficiency in a fat-soluble factor—Vitamin K. This discovery allowed surgeons to treat patients with Vitamin K before surgery, drastically reducing mortality rates.
- The Discovery of Factor V: In 1943, Quick noticed that the clotting time of stored plasma lengthened over time. He correctly hypothesized the existence of a "labile factor" (now known as Factor V) that was essential for coagulation, further refining the classical model of blood clotting.
- Aspirin and Bleeding: Later in his career, Quick was among the first to scientifically document the effect of aspirin on platelet function and bleeding time, a precursor to the modern use of aspirin as a preventative for heart attacks.
3. Notable Publications
Quick was a prolific writer, authoring over 300 scientific papers and several foundational textbooks. His most influential works include:
- "The prothrombin in hemophilia and in obstructive jaundice" (1935): Published in the Journal of Biological Chemistry, this paper introduced the Prothrombin Time test and changed hematology forever.
- "The Hemorrhagic Diseases and the Physiology of Hemostasis" (1942): This was the first comprehensive textbook on bleeding disorders, providing a roadmap for clinicians.
- "Hemorrhagic Diseases and Thrombosis" (1966): An updated synthesis of his life’s work, emphasizing the clinical management of clotting disorders.
4. Awards & Recognition
Quick’s contributions were recognized by the highest echelons of the medical and scientific communities:
-
The Albert Lasker Clinical Medical Research Award (1967): Often referred to as the "American Nobel," this was awarded to Quick for his:
"brilliant contributions to our understanding of the mechanism of blood clotting."
- Modern Medicine Distinguished Achievement Award (1957).
- Honorary Fellowships: He was a fellow of the American Association for the Advancement of Science (AAAS) and held numerous honorary memberships in international hematological societies.
- The Armand Quick Professorship: Established at the Medical College of Wisconsin to honor his legacy in biochemistry.
5. Impact & Legacy: The Safety Net of Modern Surgery
It is difficult to overstate Quick’s impact on modern medicine. Before his test, surgery was a gamble; a patient might have an undiagnosed clotting deficiency and bleed to death on the table. Today, the PT test (and its standardized version, the INR) is performed millions of times daily worldwide.
Beyond diagnosis, the Quick Test was the catalyst for the development of anticoagulant therapy. When Warfarin (Coumadin) was developed, it was the Quick Test that allowed doctors to monitor the dosage. Without his method, blood thinners would have been too dangerous to use, as there would have been no way to ensure the blood wasn't "too thin."
6. Collaborations: Bridging Chemistry and Medicine
Quick was a solitary thinker in many respects, but his work intersected with other giants of the era. He worked closely with Karl Paul Link, the University of Wisconsin chemist who discovered dicumarol (the precursor to Warfarin). While Link found the substance, it was Quick’s prothrombin test that allowed Link to measure the substance's effect on animals, making the discovery of the drug possible.
At Marquette, Quick was a beloved mentor, training a generation of biochemists and hematologists who expanded his work into the discovery of other clotting factors (Factors VII, IX, and X).
7. Lesser-Known Facts
- The "Quick" Pun: While the "Quick Test" is indeed very fast to perform (taking about 12 seconds for normal blood), it is named after Armand Quick himself, not its speed. He often joked about this coincidence.
- Self-Experimentation: Like many great scientists of his era, Quick was known to use his own blood for his initial experiments when control samples were unavailable.
- A Late Bloomer in Medicine: Quick didn't receive his MD until he was 34 years old. His "delayed" entry into clinical medicine was actually his greatest strength, as he brought a decade of high-level chemical expertise to a field that was, at the time, largely observational.
- Philosophy of Science: Quick was a vocal critic of over-complicating science. He famously advocated for simple, reproducible tests that could be performed in any hospital lab, rather than complex procedures restricted to elite research centers.